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Abstract: Seafood is currently the best and generally a safe source of long-chain (LC, 
(≥C20) omega-3 oils amongst the common food groups. LC omega-3 oils are also obtained 
in lower amounts per serve from red meat, egg and selected other foods. As global 
population increases the opportunities to increase seafood harvest are limited, therefore 
new alternate sources are required. Emerging sources include microalgae and under-
utilized resources such as Southern Ocean krill. Prospects for new land plant sources of 
these unique and health-benefiting oils are also particularly promising, offering hope for 
alternate and sustainable supplies of these key oils, with resulting health, social, economic 
and environmental benefits. 
Keywords:  long-chain omega-3; fish oils; aquaculture; algal oils; sustainable sources; 
novel land plants 
 
1. Introduction 
1.1. Long-Chain Omega-3 Oils–Definitions and Health Benefits  
Our bodies need dietary fats and oils and, whilst some are remarkably beneficial for us [1,2], other 
fats can be associated with poor health. In this manuscript we concentrate on omega-3 oils (can be 
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termed: ω3, n-3, n3; first double bond three carbons from terminal methyl end of molecule), a specific 
group of polyunsaturated fatty acids (PUFA, fatty acids are the main building blocks of most fats and 
oils). There are two different versions of omega-3 called long-chain (≥C20, LC) and short-chain (≤C18, 
SC). We focus here on the long-chain omega-3 (hereafter also termed LC omega-3) which include 
eicosapentaenoic acid (EPA, 20:5ω3), docosapentaenoic acid (DPA, 22:5ω3) and docosahexaenoic 
acid (DHA, 22:6ω3). 
The health benefits of LC omega-3 were first reported some three decades ago. Scientists observed 
that Greenland Eskimos had lower amounts of heart disease than other groups despite the fact their 
traditional diet is actually high in fat [3]. Associated with this finding was that Eskimo blood took 
longer to clot. The shorter bleeding times common in Western countries can increase the risk of 
forming a blood clot which may trigger a heart attack. Investigations found that the traditional, seafood 
rich diet of the Eskimos was responsible both for the thinner blood and the healthier hearts [4]. The 
key ingredient of this diet was found to be LC omega-3. The human body needs fats of different types 
to grow and function properly and LC omega-3 oils are particularly relevant for foetal and infant 
growth since without LC omega-3, infant and children’s vision and growth can be impaired [5,6]. The 
human body cannot produce short chain omega-3 on its own, and does not convert the short chain 
omega-3 to the long-chain versions, especially DHA, efficiently. The issue of the poor conversion 
efficiency of 18:3ω3 (α-linolenic acid, ALA) to EPA and DHA in humans is also crucial to the debate 
on sustainable sources, with fish oil or other sources of LC omega-3 clearly the preferred and 
benefitting nutrient required [7,8]. When the diet does not supply sufficient omega-3, growth can be 
impaired and vulnerability to a number of diseases can increase.  
In addition to being required for healthy growth and development, LC omega-3 have a number of 
added health benefits, particularly in helping us protect against heart and blood vessel problems. In the 
mid 1980s CSIRO researchers discovered that LC omega-3 protect against heart attacks by maintaining 
normal heart rhythm [9,10]. These early observations have now been confirmed in human clinical trails. 
The positive impact of LC omega-3 on heart health includes: protection against heart attacks by reducing 
the risk of abnormal heart rhythms; maintaining healthy blood vessels; lowering of high blood pressure; 
influencing the narrowing of arteries; and making the blood less likely to clot.  
LC omega-3 also lower high blood fats by reducing their production in the liver and purified LC 
omega-3 is available as a treatment for patients with very high blood fat levels [11]. LC omega-3 oils help 
to combat certain inflammatory conditions such as rheumatoid arthritis [12] and it has been suggested that 
they may also have a positive impact on kidney function. In addition to these purely physical health 
benefits, it has been suggested that LC omega-3 may have benefits for neuropsychiatric disorders 
including depression and dementia [13-15]. These fats may play a role in helping with mood regulation 
and maintaining good cognitive function as we age although further research is needed in these areas. 
Here we provide an update on current and potential future sources of the LC omega-3 oils. 
2. Current Sources of LC Omega-3 
The main current source of LC omega-3 oils is seafood, including fish, crustaceans, such as 
lobsters, and molluscs, such as oysters and squid. Representative values for content of LC omega-3 in 
Australian seafood groups and individual species, together with data for other food groups, is shown in 
Tables 1 and 2. Some land animals also contain LC omega-3 but generally in quite small quantities. Nutrients 2010, 2                                       
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Land plants, such as canola and linseed, contain some omega-3 although these are not the beneficial 
long-chain varieties. The short-chain omega-3 in land plants do not have the same health benefits as 
LC omega-3 [7,8].  
In Australia, CSIRO has considerable interest in LC omega-3 and, in partnership with the Fisheries 
Research and Development Corporation, has profiled the LC omega-3 content of a wide range of 
seafood [16,17]. In terms of LC omega-3, different types of fish can have widely different amounts. 
For example, white-fleshed Australian wild fish, on average, contain approximately 350 mg per 150 g 
(representative of a typical serve size) (Table 1). However, the same quantity of slender tuna has 
5,640  mg and swordfish has 1530 mg (Table 2). Different parts of the fish can contain different 
amounts of the LC omega-3. The season and location where the seafood was caught can also result in 
different contents, however, these effects are generally minor [17].  
2.1. Suggested Intake of LC Omega-3 
To gain the many health benefits noted above the recommended daily intake provided by many 
organizations for LC omega-3 can vary (see Table 3). Within Australia it is generally agreed that we 
need about 500 mg of the LC omega-3 oil daily, although current intake in Australia, UK and USA is 
estimated to be around 100–200 mg per day [18]. Two to three serves of sufficiently oily fish a week 
can help provide suitable intake levels. Higher intake is recommended for those with disorders that can 
be aided by LC omega-3 intake. The processing and cooking of seafood does not generally affect the 
LC omega-3 content [16,17], although many forms of cooking such as–e.g., grilling, pan-frying, 
baking and microwaving - are more preferable than deep frying which can add other less desirable, 
e.g., saturated, fats.  
2.2. Contaminant Concerns 
While the health benefits of seafood consumption have been known for some time, there are often 
concerns around the potential dangers from pollutants such as mercury. These concerns can discourage 
people from eating fish even though mercury contamination generally applies only to large open water 
fish such as sharks, swordfish and large tuna. From an observational cohort study, it has been stated 
that advice for limiting seafood consumption during pregnancy could actually be detrimental, with it 
being demonstrated that risks from the loss of the LC omega-3 were greater than the risks of harm 
from exposure to trace contaminants in seafood [19]. Guidelines around the amounts of large fish that 
should be consumed are publicly available. For example, see: http://www.foodstandards.gov.au/ 
foodmatters/mercuryinfish.cfm. These guidelines give special emphasis for people who may be more 
at risk from mercury, such as pregnant women. However, the warnings around excessive consumption 
of large fish have at times been seen as a warning regarding all fish. The mercury issue has also been 
overstated, as seafood contains selenium which counteracts the effects of mercury [19]. The guidelines 
around the consumption of large fish such as shark and swordfish need to be taken in account, 
although it is noted that mercury is not a problem for all fish and the health benefits from consuming 
fish and the LC omega-3 it contains far outweigh the risks [19]. 
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Table 1. Average LC omega-3 content of wild and farmed Australian seafood together 
with other food groups 
1. 
Food  mg/150 g   
(wet weight 
2) 
Wild Australian seafood     
Fish 350 
Shellfish 225 
Prawns 180 
Lobster 160 
 
Farmed Australian fish 
  
Striped perch  3,700 
Atlantic salmon  2,985 
Barramundi 2,960 
Silver perch  1,200 
 
Other food groups 
  
Turkey 40 
Beef 40 
Chicken 40 
Pork 40 
Lamb 30 
1 Data from [16,17], includes EPA, DPA and DHA 
2 150 g is representative of a typical serve size. 
Table 2. Wild-caught Australian seafood containing more than 450 mg/150 g (raw) of LC 
omega-3, data derived from [16,17]. 
Marketing Name  Scientific Name 
Oil 
(g/100g)  
Total LC 
omega-3 
1 
(mg/150 g)  
Slender tuna  Allothunnus fallai  16.5 5,640 
Swordfish  Xiphias gladius  7.7 1,530 
Escolar 
2  Ruvettus pretiosus  17.8 1,530 
Banded morwong  Cheilodactylus spectablis  3.2 1,230 
Alfonsino  Beryx splendens  5.2 1,195 
Whitebait  Lovettia sealii  2.6 1,100 
Escolar 
2  Lepidocybium flavobrunneum  19.2 1,075 
Big-eye trevally  Caranx sexfasciatus  4.7 1,065 
Whitebait  Galaxias maculatus  3.3 1,030 
Blue mackerel  Scomber australasicus  3.8 760 
Australian bonito  Sarda australis  1.5 650 
Gemfish  Rexea solandri  2.6 640 
Rudderfish  Centrolophus niger  14.4 620 
Spanish mackerel  Scomberomorus commerson  3 575 Nutrients 2010, 2                                       
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Table 2. Cont. 
Sweep  Scorpis lineolatus  1.3 555 
Australian herring  Arripis georgianus  1.7 540 
Western blue grouper  Achoerodus gouldii  3.6 540 
Bigspine boarfish  Pentaceros decacanthus  1.5 530 
Eastern Australian 
salmon  Arripis trutta  1.1 505 
Spotted mackerel  Scomberomorus munroi  1.2 500 
School mackerel 
Scomberomorus 
queenslandicus  1.1 490 
Grey mackerel 
Scomberomorus 
semifasciatus  1.1 490 
Tailor  Pomatomus saltatrix  1.3 490 
Threadfin emperor  Lethrinus genivittatus  2.6 490 
Bight redfish  Centroberyx gerrardi  0.5 485 
Pilchard  Sardinops neopilchardus  1.2 470 
Blue eye trevalla  Hyperoglyphe antarctica  1.3 470 
1 includes EPA, DPA and DHA 
2 consumption of escolar may cause illness 
 
2.3. Sustainability of Current Sources of LC Omega-3 
 
Against the increasingly recognized literature and other public materials available on the health 
benefits of LC omega-3 oils, the global decline in wild-harvest fish stocks is also a more recently 
recognized issue. In a widely-cited study [15], it was estimated that the amount of large fish in the 
oceans is only 10% of pre-industrial times, although this has been disputed [16]. It has been further 
stated that ocean and fish stock health are considered so under threat that by 2048 ‘all commercial fish 
and seafood may collapse’ [17]. This view on the state of the world’s fisheries is not unanimous with 
recent progress establishing some common ground between the sometimes opposing views. Progress is 
also being made by many countries towards rebuilding global fisheries and sustainability and different 
approaches are required for industrial fisheries compared to small-scale fisheries [18]. An interesting 
aspect in the equation is that the environmental impact of marine fisheries is seen as much less than for 
production of  animal protein from agriculture that requires the removal of forest and in many 
dimensions is also less than for vegetarian diets. (Ray Hilborn, personal communication). 
Australian research has also shown that stocks of up to 60 species e.g., eastern gemfish, snapper in 
NSW and WA, are under pressure from environmental damage and over fishing [19], although in 
general Australian marine resources are regarded as well managed [20]. These declines, when coupled 
with the ongoing growth of world aquaculture, increasing world population coupled with increased 
seafood consumption in western diets, means that new sources of LC omega-3 oil are required. 
Several calculations have been recently performed to examine global consumer needs for the 
health-benefiting LC omega-3 oils [21]. Using - a daily 500 mg requirement as is recommended by 
many bodies, a global population reaching 8 billion by 2025 (United Nations estimate in 2007), and Nutrients 2010, 2                                       
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assuming fish contain 2 to 5 mg/100 g oil, it was estimated that the current global fish harvest   
(93 Mt per annum) will not supply this requirement. A second calculation performed for table fish, 
assuming an average LC omega-3 content of 450 mg/150 g flesh (average serve size), a harvest of 
70 Mt, and 50% edible portion. Neither calculation takes into account processing inefficiencies, which 
therefore further emphasizes a predicted shortfall in fisheries catch meeting global needs for the unique 
and health benefiting LC omega-3 oils. 
Table 3. Selected suggested LC omega-3 (EPA + DHA) intakes for adults available from 
various agencies and bodies. 
Authority / Group  mg/day 
   
Omega Workshop, Adelaide, Australia, 2002 [20]  300–400 
SACN/COT, UK 2004 [21]  450 
   
National Heart Foundation, 2008 [22]  500 
   
American Dietetic Association and Dietitians of Canada, 2007 [23]   500 
FAO/WHO Expert Consultation, 2008 [24]  250–2,000* 
   
American Heart Association, 2002 [25]    
Coronary Heart Disease sufferers  1,000 
        Those seeking to reduce triacylglycerols (blood fats)   2,000–4,000 
     
Australia and New Zealand (suggested dietary targets), 2006 [26]    
Female 430 
Male 610 
* for secondary prevention of coronary heart disease 
3. Fish farming: Current Status and Looking to the Future 
Over the past two decades the farming of fish has increased considerably. The amount of farmed 
fish on the market will soon surpass that of wild caught fish [37]. From an environmental point of view 
this seems very positive as the pressures on wild fish stocks can be quite severe as noted above. 
Beyond concerns for the environment it is also becoming increasingly clear that global fish stocks will 
not be able to meet human’s nutritional needs in the future [36]. Hence, farming fish appears to be a 
good opportunity to increase both global production and consumer needs.  
As aquaculture expanded in the past decades, most carnivorous and many omnivorous farmed fish 
were initially all fed other fish (e.g., tuna ranching) or fish-derived products in pellet form generally 
comprising fish meal and fish oil as the major ingredients (e.g., salmon farming). Wild fish stocks 
were being harvested and used to feed the farmed fish. Due to increasing global demand for fish oil 
and environmental issues more and more suppliers are starting to use plant-based and other sources of 
ingredients and oils as feed for their fish [35,37,38]. However, the problem for consumers is that 
farmed fish do not naturally produce large quantities of LC omega-3, since in the wild fish gain their Nutrients 2010, 2                                       
 
578
LC omega-3 from small aquatic plants, microalgae, that are consumed at the bottom of the marine food 
chain. The LC omega-3 oil is then passed up the food chain and stored in the fish bodies. As land 
plants produce the far less useful short chain (C18) omega-3, feeding fish on land plant derived oils 
containing the short chain ALA results in far lower accumulation of LC omega-3 in the farmed fish 
and consumers do not gain the same health benefits. 
In contrast, farmed fish can have even higher concentrations of LC omega-3 than fish caught in the 
wild when fed on fish oil based diets. For instance, the main farmed fish in Australia, such as 
Tasmanian Atlantic salmon from southern waters and barramundi from northern waters, provide up to 
10 times more LC omega-3 (~3,000 mg/150g) than the average wild fish (Table 1). Until recent years 
Australian and New Zealand fish farms were largely using fish products in feed so the LC omega-3 
content remained high. Further pressures on wild fish stocks will likely result in increased use of oils 
derived from land plants and or other ingredients in feeds, with: (i) lower relative levels (as % of total 
fatty acids), (ii) lower absolute content of the LC omega-3 oil and (iii) lower ω3 to ω6 ratio resulting 
than has previously occurred in farmed fish [34]. As the relative levels of these key LC omega-3 oils 
decrease, linoleic acid (LA, 18:2ω6) and oleic acid (OA, 18:1ω9c) increase; OA and LA are derived 
from the non-marine ingredients that are being increasingly substituted into aquafeeds [35]. However, 
farmed seafood species generally still remain an excellent source of the LC omega-3 oils. In Australia 
for example, farmed Tasmanian Atlantic salmon is widely available and remains an excellent source of 
LC omega-3 oil (1,610 mg/150 g serve, unpublished data 2010), clearly one of the best of all foods 
available for consumers. 
A number of avenues can be considered for turning the current trend in LC omega-3 oils in farmed 
fish around. Practices at fish farms could be examined to make better use of the wild fish stocks, and 
also using ‘finishing diets’; the latter involves feeding fish on diets comprising plant or other 
ingredients during the grow-out phase, followed by the use of a fish oil diet during the final finishing 
period prior to harvest [37]. Making better use of current wild harvest ‘waste’ products, such as the 
liver and head, as sources of LC omega-3 oils, also could be expanded. The range of fish used could be 
widened, including species such as the underutilized Antarctic krill. Krill oil has attracted increasing 
interest in recent years and contains high (~30%) relative levels of EPA and DHA together with the 
carotenoid pigment astaxanthin, with much of the LC omega-3 present in phospholipids rather than the 
conventional triacylglycerol form that occurs in fish oil [34]. Considerable caution would be needed 
for increasing the harvest of this species as it underpins the Southern Ocean food web. The problem 
still remains of decreasing wild fish stocks and the need for farmed fish to also have high amounts of 
the LC omega-3.  
4. New Alternate Sources of LC Omega-3 
A number of options are currently being explored to assist with potential future problems of 
decreased populations of wild fish and the health and nutritional needs of consumers. Sources of LC 
omega-3 are currently being developed from microalgae by several companies [35,39,40], with 
considerable interest in single cell organisms (SCO) such as heterotrophic dinoflagellates and 
thraustochytrids and some species from other algal groups. Thraustochyrids were originally thought to 
be closely related to primitive fungi, although have more recently been assigned to the subclass 
Thraustochytridea (Chromista, Heterokonta), aligning them with heterokont algae such as diatoms and Nutrients 2010, 2                                       
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brown algae [41]. Whilst SCO sources are finding increasing use in infant formulas and other niche 
areas including nutrition of fish larvae, it is presently generally considered too expensive for use in fish 
farming, which is the current main user (~90% of global production) of fish oil containing LC omega-3 
oils. As more research is conducted, including in the growing field of biofuels, it may be possible to 
reduce production costs for microalgae. The genetic modification of microorganisms such as yeast to 
produce LC omega-3 is also a future possibility. Yeast and similar bioproducts may be targeted as they 
can easily be fermented on a large scale, potentially making the production of LC omega-3 oil 
relatively efficient [42]. 
In an alternative approach to the use of microorganisms, a number of international teams are now 
using genetic engineering technology to allow land plant crops to produce the health-benefitting LC 
omega-3 oils (see Table 4); several reviews are available and provide summaries of the considerable 
progress to date towards this goal [43,44]. This alternative approach to obtaining LC omega-3 oils has 
resulted from concerns on over-fishing and about pollution of the marine environment [35,36,44], in 
addition to the increasing recognition of the enormous health and socio-economic benefits of these oils 
and the expanding global population and finally the clear need for new sustainable sources.  
There are two distinct pathways leading to the biosynthesis of LC-PUFA in nature: 1. The 
conventional (aerobic) fatty acid desaturation/elongation pathway, and 2. The anaerobic polyketide 
synthase (PKS) pathway. The PKS route is similar to those involving the PKS complexes in antibiotic 
synthesis. No reports of successful expression of the PKS pathway in land plants have emerged to date. 
In contrast, insertion of the aerobic pathway leading to DHA production, into omega-3 C18 PUFA 
accumulating land plants, has been reported in a number of studies. Transfer of genes from 
microorganisms to land plants led to accumulation of 2.4% EPA and 0.5% DHA in Arabidopsis 
(Mouseear cress, later improved to 4% EPA and 1% DHA) [45]–(the first reporting of a (model) land 
plant with DHA), 15% EPA and 0.2% DHA in Brassica juncea (Indian mustard) [46], 19.6% EPA and 
3.3% DHA in soybean (Table 4) [47].  
These initial findings from a number of research teams clearly indicate the feasibility of developing 
grain crops with significant amounts of LC omega-3 oil. Further research is required to develop 
commercial oilseed crops with LC omega-3 oil and increased levels of DHA in particular are still 
required. It is interesting to point out, that as little as one tablespoon (~10 mL) of soybean oil 
containing 20% of EPA could make a significant contribution to the recommended dietary intake of 
the beneficial omega-3 LC-PUFA. Considerable effort is now being focused on increasing the levels of 
DHA and it is not unrealistic to hope that DHA levels of 20% can be achieved in transgenic plants in 
the next few years.  
Future novel land-based plants will likely provide the most economically viable source LC omega-3 
oil for aquaculture and other applications. A land plant source of LC omega-3, if achieved and 
assuming their cultivation will be permitted, will be cheaper than using yeast or microalgae and could 
be used in fish feeds and other feed and food products to help deliver increased human health benefits 
[35,42]. Research involving the use of microbial genes in land plants has so far led to increases the 
production of LC omega-3 in a number of land plant species (Table 4). This future may be as little as 
five years away [48], although perhaps longer in the context of aquaculture feeds and for products for 
direct human consumption in particular to meet all the permitting requirements that are likely to be in 
place in 15 years [35,42]. Nutrients 2010, 2                                       
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Figure 1. Schematic representation of fatty acid pathway for new land plants containing 
EPA and DHA, with incorporation on selected microalgae-derived genes. Although the Δ6 
route is shown here, another pathway for LC omega-3 biosynthesis (Δ9, from ALA) also 
exists. 
18:1 18:0 18:2 16:0 α−18:3
∆6-des
∆5-elo
∆4-des
∆5-des
∆6-elo
18:4
DHA
EPA
SDA
20:5
20:4
22:6
22:5 Marine
Algae
Land Plants
 
Table 4. Comparison of fatty acid composition (expressed as g/100 g of total fatty acids) 
for new land plants containing the C18 omega-3 PUFA stearidonic acid, arachidonic acid or 
LC omega-3 oils. 
  Ref  SDA EPA ARA DHA 
CSIRO: oilseeds 
(includes model 
plants) 
[49] 10       
[45]   5   1 
[49] 1  26  2   
[50]     22  
BASF: mustard  [46]    15  7  1.5 
Monsanto: soya bean  [51]  20       
Dupont: soya bean  [47]    20    3 
Farmed salmon 
Fed fish oil diet 
Fed plant oil diet 
        
[16,17]   10    17 
[52]   2.2    5 
Abbreviations: SDA, stearidonic acid EPA; EPA, eicosapentaenoic acid; ARA, arachidonic 
acid; DHA, docosahexaenoic acid. 
 
Research in the area of land plant sources of LC omega-3 has the potential for significant health, 
social, environmental and commercial benefits. Consumer and industry acceptance of this 
biotechnology and new health and safety requirements set by regulatory bodies will be needed for oils 
from these novel land plants before they can be used by the aquaculture and other industries. Nutrients 2010, 2                                       
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Recentassessments of perceived consumer acceptance of novel land plant LC omega-3 technologies in 
Australia and the USA have reported that farmed fish were preferred as a delivery mechanism over 
capsules or functional foods [53,54]. It is likely that consumers will accept oil from a GM crop as an 
ingredient of aquafeeds as demand for fish oil intensifies, as knowledge about fishing impacts and 
benefits to human health of LC omega-3 increases, and as farmed fish prices decrease owing to 
reduced ingredient costs [35].  
Considerable effort is now being focused on increasing the levels of LC omega-3 in land plants and 
it is not unrealistic to foresee that sufficiently high concentrations can be reached in the next few years. 
Similarly, research is needed to open up new avenues for delivery of LC omega-3 oils to consumers 
via grains including e.g. whole grains in foods, vegetative plant tissues, extracted oil in spreads, 
extracted oils as food ingredients and aquaculture and livestock feeds. 
5. Conclusion 
LC omega-3 oils are required for ongoing health and vitality and to provide consumers with 
benefits across a range of areas, including heart disease, stroke, rheumatoid arthritis, some forms of 
cancer and other disorders. It is recognized that an increase in LC omega-3 consumption is required, 
which, currently, means at least two serves of appropriately oily fish per week. Future supplies of the 
beneficial LC omega-3 oils may not be sufficient for the predicted increasing demands for their 
inclusion in both feeds and food and nutraceutical products. In addition, with the wild harvest fisheries 
from which the LC omega-3 are obtained under threat, we need to explore alternate means to ensure 
their future supply while still protecting the environment and ocean life. Potential alternate sources of 
LC omega-3 for use in aquaculture and other application areas include single cell microalgal oils 
and/or biomass, and under-utilized marine sources including krill, although expanding the fishing of 
these building blocks of the marine ecosystem should be carefully considered before a marked increase 
in exploitation of krill resources occurs. Finally, the exciting prospect is evolving for the further 
development and application of novel transgenic oilseeds with several research groups active in   
this area. 
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